Ohyama Takao | Biologics Research Laboratories Daiichi Sankyo Co. Ltd.
スポンサーリンク
概要
関連著者
-
Sogawa Yoshitaka
Cardiovascular-metabolics Research Laboratories Daiichi Sankyo Co. Ltd.
-
Ohyama Takao
Biologics Research Laboratories Daiichi Sankyo Co. Ltd.
-
Maeda Hiroaki
Frontier Research Laboratories Daiichi Sankyo Co. Ltd.
-
Hirahara Kazuki
Biological Research Laboratories Iii Daiichi Sankyo Co. Ltd.
-
Hirahara Kazuki
Frontier Research Laboratories Daiichi Sankyo Co. Ltd.
-
Sogawa Yoshitaka
Cardiovascular-Metabolics Research Laboratories, Daiichi Sankyo Co., Ltd., Japan
-
Ohyama Takao
Biologics Research Laboratories, Daiichi Sankyo Co., Ltd., Japan
-
Maeda Hiroaki
Frontier Research Laboratories, Daiichi Sankyo Co., Ltd., Japan
-
Hirahara Kazuki
Frontier Research Laboratories, Daiichi Sankyo Co., Ltd., Japan
-
MAEDA Hiroaki
Biological Research Laboratories, Sankyo Co., Ltd.
-
SOGAWA Yoshitaka
Biological Research Laboratories III, Daiichi Sankyo Co., Ltd.
-
SHIMIZUGAWA Akiko
Exploratory Research Laboratories I, Daiichi Sankyo Co., Ltd.
-
OHYAMA Takao
Exploratory Research Laboratories II, Daiichi Sankyo Co., Ltd.
-
HIRAHARA Kazuki
Biological Research Laboratories III, Daiichi Sankyo Co., Ltd.
-
Maeda Hiroaki
Biological Research Laboratories Sankyo Co. Ltd.
-
Shimizugawa Akiko
Exploratory Research Laboratories I Daiichi Sankyo Co. Ltd.
-
Maeda Hiroaki
Biological Research Laboratories III, Daiichi Sankyo Co., Ltd., Japan
著作論文
- Formyl Peptide Receptor 1 and 2 Dual Agonist Inhibits Human Neutrophil Chemotaxis by the Induction of Chemoattractant Receptor Cross-desensitization
- The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX-Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist
- Formyl Peptide Receptor 1 and 2 Dual Agonist Inhibits Human Neutrophil Chemotaxis by the Induction of Chemoattractant Receptor Cross-desensitization